Related references
Note: Only part of the references are listed.Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug
Tali H. Reingewertz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis
Vadim Makarov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Building a tuberculosis-free world: The Lancet Commission on tuberculosis
Michocd J. A. Reid et al.
LANCET (2019)
Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis
Nathan D. Hicks et al.
MBIO (2019)
Type VII Secretion Substrates of Pathogenic Mycobacteria Are Processed by a Surface Protease
Maroeska J. Burggraaf et al.
MBIO (2019)
Mycobacterium tuberculosis virulence inhibitors discovered by Mycobacterium marinum high-throughput screening
Hasan Tukenmez et al.
SCIENTIFIC REPORTS (2019)
Accelerating Early Antituberculosis Drug Discovery by Creating Mycobacterial Indicator Strains That Predict Mode of Action
Maikel Boot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment
Christoph Lange et al.
RESPIROLOGY (2018)
Screening of anti-mycobacterial compounds in a naturally infected zebrafish larvae model
J. P. Dalton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide
Michelle L. T. Ang et al.
FRONTIERS IN MICROBIOLOGY (2017)
A fluorescence-based reporter for monitoring expression of mycobacterial cytochrome bd in response to antibacterials and during infection
Maikel Boot et al.
SCIENTIFIC REPORTS (2017)
Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of ethA as a Mechanism of Ethionamide Resistance
Lynne de Welzen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Update of Antitubercular Prodrugs from a Molecular Perspective: Mechanisms of Action, Bioactivation Pathways, and Associated Resistance
Julie Laborde et al.
CHEMMEDCHEM (2017)
New prodrugs against tuberculosis
Giorgia Mori et al.
DRUG DISCOVERY TODAY (2017)
Evaluation of the SLOMYCO Sensititre® panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates
Marion Chazel et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2016)
Application of Fluorescent Protein Expressing Strains to Evaluation of Anti-Tuberculosis Therapeutic Efficacy In Vitro and In Vivo
Ying Kong et al.
PLOS ONE (2016)
Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis Inhibitors
Sarah Schmidt Grant et al.
CELL CHEMICAL BIOLOGY (2016)
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG
Giorgia Mori et al.
CHEMISTRY & BIOLOGY (2015)
Development of a Mycobacterium smegmatis transposon mutant array for characterising the mechanism of action of tuberculosis drugs: Findings with isoniazid and its structural analogues
Richard L. Campen et al.
TUBERCULOSIS (2015)
Tuberculosis Treatment and Drug Regimens
Giovanni Sotgiu et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Interception of host angiogenic signalling limits mycobacterial growth
Stefan H. Oehlers et al.
NATURE (2015)
Animal Models of Tuberculosis: Zebrafish
Lisanne M. van Leeuwen et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
Vadim Makarov et al.
EMBO MOLECULAR MEDICINE (2014)
Ligand Efficiency Driven Design of New Inhibitors of Mycobacterium tuberculosis Transcriptional Repressor EthR Using Fragment Growing, Merging, and Linking Approaches
Baptiste Villemagne et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities
Catherine Vilcheze et al.
MICROBIOLOGY SPECTRUM (2014)
Mycobacterium marinum infection in Drosophila melanogaster for antimycobacterial activity assessment
Chun-Taek Oh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Robotic injection of zebrafish embryos for high-throughput screening in disease models
Herman P. Spaink et al.
METHODS (2013)
Ectoine Biosynthesis in Mycobacterium smegmatis
Naomi Ofer et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2012)
Molecular Investigation of Resistance to the Antituberculous Drug Ethionamide in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis
F. Brossier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Taking phage integration to the next level as a genetic tool for mycobacteria
Jason Huff et al.
GENE (2010)
Sensitive Detection of Gene Expression in Mycobacteria under Replicating and Non-Replicating Conditions Using Optimized Far-Red Reporters
Paul Carroll et al.
PLOS ONE (2010)
Synthetic EthR inhibitors boost antituberculous activity of ethionamide
Nicolas Willand et al.
NATURE MEDICINE (2009)
EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets
Lynn G. Dover et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The prodrug activator EtaA from Mycobacterium tuberculosis is a Baeyer-Villiger monooxygenase
MW Fraaije et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator
J Engohang-Ndong et al.
MOLECULAR MICROBIOLOGY (2004)
Mycobacterium marinum strains can be divided into two distinct types based on genetic diversity and virulence
AM van der Sar et al.
INFECTION AND IMMUNITY (2004)
The antituberculosis drug ethionamide is activated by a flavoprotein monooxygenase
TA Vannelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
AE DeBarber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Incubation period and sources of exposure for cutaneous Mycobacterium marinum infection:: Case report and review of the literature
JA Jernigan et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
